The effects of FK506 on dorsal column axons following spinal cord injury in adult rats: Neuroprotection and local regeneration

Experimental Neurology

Volumn 158, Issue 2, 1999, Pages 382-393

  Bavetta, Seb ^a   Hamlyn, Peter J ^b   Burnstock, Geoffrey ^a   Lieberman, A Robert ^a   Anderson, Patrick N ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Axon regeneration; FK506; Immunophilin ligands; Neuroprotection; Spinal cord injury

Indexed keywords

CHOLERA TOXIN B SUBUNIT; IMMUNOPHILIN; METHYLPREDNISOLONE; TACROLIMUS;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; GRACILE NUCLEUS; NERVE CRUSH; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SPINAL CORD INJURY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032816454     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7119     Document Type: Article

References (61)

1. Aigner L., Arber S., Kaphammer J. P., Laus T., Schneider C., Botteri F., Brenner H.-R., Caroni P. Overexpression of the neural growth-associated protein GAP-43 induces nerve sprouting in the adult nervous system of transgenic mice. Cell. 83:1995;269-278.
2. Bartholdi D., Schwab M. E. Methylprednisolone inhibits early inflammatory processes but not ischaemic cell death after experimental spinal cord lesion in the rat. Brain Res. 672:1995;177-186.
3. Blight A. R. Effects of silica on the outcome from experimental spinal cord injury: Implication of macrophages in secondary tissue damage. Neuroscience. 60:1994;263-273.
4. Bracken M. B., Shepard M. J., Collins W. F., Holford T. R., Young W., Baskin D. S., Eisenberg H. M., Flamm E., Summers L. Leo, Maroon J., Marshall L. F., Perot P. L., Piepmeier J., Sonntag V. K. H., Wagner F. C., Wilberger J. L., Winn H. R. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury. N. Engl. J. Med. 322:1990;1405-1411.
5. Bracken M. B., Shepard M. J., Collins W. F. Jr., Holford T. R., Baskin D. S., Eisenberg H. M., Flamm E., Summers L. Leo, Maroon J. C., Marshall L. F., Phanor L. P. Jr., Piepmier J., Sonntag V. K. H., Wagner F. C. Jr., Wilberger J. L., Winn H. R., Young W. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. J. Neurosurg. 76:1992;22-31.
6. Buschmann T., Winter C., Martin-Villalba A., Schenkel J., Zimmermann M., Herdegen T. The translocation of c-Jun n-terminal kinase-2 (JNK-2,SAPK) into the nucleus of apoptic adult neurons following UV-irradiation is antagonized by the immunosuppressant FK-506. Soc. Neurosci. Abstr. 23:1997;2225.
7. Butcher S. P., Henshall D. C., Teramura Y., Iwasaki K., Sharkey J. Neuroprotective actions of FK506 in experimental stroke: In vivo evidence against an antiexcitotoxic mechanism. J. Neurosci. 17:1997;6939-6946.
8. Chong M. S., Woolf C. J., Turmaine M., Emson P. C., Anderson P. N. Intrinsic versus extrinsic factors in determining the regeneration of the central processes of rat dorsal root ganglion neurons: The influence of a peripheral nerve graft. J. Comp. Neurol. 370:1996;97-104.
9. Constantini S., Young W. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 80:1994;97-111.
10. Das G. D. Perspectives in anatomy and pathology of paraplegia in experimental animals. Brain Res. Bull. 22:1989;7-32.
11. Dawson, T. M., J. P. Steiner, V. L. Dawson, J. L. Dinerman, G. R. Uhl, and S. H. Snyder. 1993. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc. Natl. Acad. Sci.USA90: 9808-9812.
12. Dawson V. L., Dawson T. M., London E. D., Bredt D. S., Snyder S. H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
13. Drake M., Friberg H., Boris-Moller F., Sakata K., Wieloch T. The immunosuppressant FK506 ameliorates ischaemic damage in the rat brain. Acta Physiol. Scand. 158:1996;155-159.
14. Dusart I., Schwab M. E. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur. J. Neurosci. 6:1994;712-724.
15. Faden A. I. Experimental neurobiology of central nervous system trauma. Crit. Rev. Neurobiol. 7:1993;175-186.
16. Folbergrova J., Li P. A., Uchino H., Smith M. L., Siesjo B. K. Changes in the bioenergetic state of rat hippocampus during 2.5 min of ischemia, and prevention of cell damage by cyclosporin A in hyperglycemic subjects. Exp. Brain Res. 114:1997;44-50.
17. Gold B. G., Katoh K., Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15:1995;7509-7516.
18. Gold B. G., Storm-Dickerson T., Austin D. R. The immunosuppressant FK-506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 6:1994;287-296.
19. Gold B. G., Zeleny-Pooley M., Wang M. S., Chaturvedi P., Armistead D. M. A nonimmunosupressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147:1997;269-278.
20. Gold B. G., Zeleny-Pooley M., Wang M. S., Chaturvedi P., Armistead D. M., McCaffrey P. G. FKBP ligands speed functional recovery and nerve regeneration in the rat sciatic nerve following oral administration. Soc. Neurosci. Abstr. 23:1997;1131.
21. Groves M. J., Ng Y. W., Ciardi A., F, Scaravilli. Sciatic nerve injury in the adult rat: Comparison of effects on oligosaccharide, CGRP and GAP43 immunoreactivity in primary afferents following two types of trauma. J. Neurocytol. 25:1996;219-231.
22. Hall E. D. The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76:1992;22-31.
23. Hugon I., Lesort M., Terro F., Dussartre C., Esclaire F. FK506 markedly reduces apoptosis and c-Jun protein expression in serum-deprived neuronal cultures. Soc. Neurosci. Abstr. 23:1997;1715.
24. Ide T., Morikawa E., Kirino T. An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the mongolian gerbil. Neurosci. Lett. 204:1996;157-160.
25. Kitamura Y., Itano Y., Kubo T., Nomura Y. Suppressive effect of FK-506, a novel immunosuppressant, against MPTP-induced dopamine depletion in the striatum of young C57BL/6 mice. J. Neuroimmunol. 50:1994;221-224.
26. Li P. A., Uchino H., Elmer E., Siesjo B. K. Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia. Brain Res. 753:1997;133-140.
27. Lipton S. A., Choi Y. B., Pan Z. H., Lei S. Z., Chen H. S., Sucher N. J., Loscalzo J., Singel D. J., Stamler J. S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
28. Liu J., Farmer J. D. J., Lane W. S., Friedman J., Weissman I., Schreiber S. L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
29. Lundborg G. Nerve Injury and Repair. 1988;Churchill Livingstone.
30. Lyons W. E., George E. B., Dawson T. M., Steiner J. P., Snyder S. H. Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia. Proc. Natl. Acad. Sci. USA. 91:1994;3191-3195.
31. Madsen J. R., Macdonald P., Irwin N., Benowitz L. I. FK-506 improves behavioral recovery and upregulates neuronal expression of GAP-43 after spinal cord injury in rats. Soc. Neurosci. Abstr. 22:1996;264.
32. Madsen J. R., Macdonald P., Irwin N., Goldberg D. E., Yao G.-L., Meiri K. F., Rimm I. J., Steig P. E., Benowitz L. I. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats. Exp. Neurol. 154:1998;673-683.
33. Matsuura K., Kabuto H., Makino H., Ogawa N. Cyclosporin A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain. Brain Res. 733:1996;101-104.
34. Matsuura K., Kabuto H., Makino H., Ogawa N. Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice. Neurosci. Lett. 230:1997;191-194.
35. Matsuura K., Makino H., Ogawa N. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine. Exp. Neurol. 146:1997;526-535.
36. Nishinaka Y., Sugiyama S., Yokota M., Saito H., Ozawa T. Protective effect of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart. J. Cardiovasc. Pharmacol. 21:1993;448-454.
37. Oudega M., Varon S., Hagg T. Regeneration of adult rat sensory axons into intraspinal nerve grafts: Promoting effects of conditioning lesion and graft predegeneration. Exp. Neurol. 129:1994;194-206.
38. Palladini G., Caronti B., Pozzessere G., Teichner A., Buttarelli F. R., Morselli E., Valle E., Venturini G., Fortuna A., Pontieri F. E. Treatment with cyclosporine A promotes axonal regeneration in rats submitted to transverse section of the spinal cord. II. Recovery of function. J. Hirnforsch. 37:1996;145-153.
39. Richardson P. M., Issa V. M. K. Peripheral nerve injury enhances central regeneration of primary sensory neurones. Nature. 309:1984;791-793.
40. Richardson P. M., Verge V. M. K. Axonal regeneration in dorsal spinal roots is accelerated by peripheral axonal transection. Brain Res. 411:1987;406-408.
41. Sakai K., Date I., Yoshimoto Y., Arisawa T., Nakashima H., Furuta T., Asari S., Ohmoto T. The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents. Brain Res. 565:1991;167-170.
42. Schreiber S. L. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science. 251:1971;283-287.
43. Shapiro R., Fung J. J., Jain A. B., Parks P., Todo S., Starzl T. E. The side effects of FK 506 in humans. Transplant. Proc. 22:1990;35-36.
44. Sharkey J., Butcher S. P. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia. Nature. 371:1994;336-339.
45. Showstack J., Katz P., Amend W., Bernstein L., Lipton H., O'Leary M., Bindman A., Salvatierra O. The effect of cyclosporine on the use of hospital resources for kidney transplantation. N. Engl. J. Med. 321:1989;1086-1092.
46. Skene J. H. P. Axonal growth-associated proteins. Annu. Rev. Neurosci. 12:1989;127-156.
47. Snyder S. H., Sabatini D. M., Lai M. M., Steiner J. P., Hamilton G. S., Suzdak P. D. Neural actions of immunophilin ligands. Trends Pharmacol. Sci. 19:1998;21-26.
48. Starzl T. E., Todo S., Fung J., Demetris A. J., Venkataramman R., Jain A. FK 506 for liver, kidney, and pancreas transplantation. Lancet. 2:1989;1000-1004.
49. Steiner J. P., Connolly M. A., Valentine H. L., Hamilton G. S., Dawson T. M., Hester L., Snyder S. H. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nature (Med.). 3:1997;421-428.
50. Steiner J. P., Dawson T. M., Fotuhi M., Glatt C. E., Snowman A. M., Cohen N., Snyder S. H. High brain densities of the immunophilin FKBP colocalized with calcineurin. Nature. 358:1992;584-587.
51. Steiner J. P., Hamilton G. S., Ross D. T., Valentine H. L., Guo H., Connolly M. A., Liang S., Ramsey C., Li J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A., Suzdak P. D. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA. 94:1997;2019-2024.
52. Teichner A., Morselli E., Buttarelli F. R., Caronti B., Pontiere F. E., Venurini G., Palladini G. Treatment with cyclosporine A promotes axonal regeneration in rats submitted to transverse section of the spinal cord. J. Hirnforsch. 34:1993;343-349.
53. Tokime T., Nozaki K., Kikuchi H. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil. Neurosci. Lett. 206:1996;81-84.
54. Uchino H., Elmer E., Uchino K., Lindvall O., Siesjo B. K. Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat. Acta Physiol. Scand. 155:1995;469-471.
55. Verdu E., Navarro X. Comparison of immunohistochemical and functional reinnervation of skin and muscle after peripheral nerve injury. Exp. Neurol. 146:1997;187-198.
56. Wang M. S., Gold B. G. FK506 increases axonal elongation in a predegenerated peripheral nerve autograft inserted into the spinal cord. Soc. Neurosci. Abstr. 23:1997;1726.
57. Wang M. S., Zeleny-Pooley M., Gold B. G. Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in the rat sciatic nerve. J. Pharmacol. Exp. Ther. 282:1997;1084-1093.
58. Yagita Y., Kitagawa K., Matsushita K., Taguchi A., Mabuchi T., Ohtsuki T., Yanagihara T., Matsumoto M. Effect of immunosuppressant FK506 on ischemia-induced degeneration of hippocampal neurons in gerbils. Life Sci. 59:1996;1643-1650.
59. Young W. Secondary injury mechanisms in acute spinal cord injury. J. Emerg. Med. 11:1993;13-22.
60. Zhang Y., Winterbottom J. K., Schachner M., Lieberman A. R., Anderson P. N. Tenascin-C expression and axonal sprouting following injury to the spinal dorsal columns in the adult rat. J. Neurosci. Res. 49:1997;433-450.
61. Zhang Z., Krebs C. J., Guth L. Experimental analysis of progressive necrosis after spinal cord trauma in the rat: Etiological role of the inflammatory response. Exp. Neurol. 143:1997;141-152.